Showing results (31-40 of 273) with videos related to
Sort By:
Pageof 28
Trends in Molecular Medicine|December 15, 2010
Mitophagy: the latest problem for Parkinson's diseaseCristofol Vives-Bauza, Serge PrzedborskiNature Protocols|April 3, 2007
Protocol for the MPTP mouse model of Parkinson's diseaseVernice Jackson-Lewis, Serge PrzedborskiExpert Opinion on Drug Safety|February 21, 2015
Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's diseaseMeir Kestenbaum, Stanley FahnCNS Drugs|July 13, 2015
Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's DiseaseDaphne Robakis, Stanley FahnNeurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Neurodegeneration and neuroprotection in Parkinson diseaseStanley Fahn, David SulzerIUBMB Life|August 27, 2003
Nitric oxide and reactive oxygen species in Parkinson's diseaseKim Tieu, Harry Ischiropoulos, Serge PrzedborskiCold Spring Harbor Perspectives in Medicine|July 28, 2025
The Mitochondrial Connection in Parkinson's DiseaseEric Schon, Diana Matheoud, Serge PrzedborskiAnnals of the New York Academy of Sciences|December 17, 2008
Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significanceChun Zhou, Yong Huang, Serge PrzedborskiCurrent Neurology and Neuroscience Reports|June 5, 2012
Botulinum toxin for the treatment of movement disordersMary Ann Thenganatt, Stanley FahnNeurology|April 6, 2016
Levodopa therapy for Parkinson disease: A look backward and forwardPeter A LeWitt, Stanley FahnPageof 28